Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Exact Sciences, a developer of patient-friendly screening technologies for detection of cancer, has appointed Michael Singer to its board of directors.
Subscribe to our email newsletter
Mr Singer is CEO of The BrainScope Company, a privately held neurotechnology company. Mr Singer has held executive level positions at Revolution, where he was instrumental in the recent merger of Revolution Health with Waterfront Media, at Microsoft and at Data Critical, where he was also a member of the board of directors and which was sold to General Electric.
Previously, Mr Singer worked as a mergers and acquisitions investment banker at New York-based Wolfensohn & Co. Mr Singer holds a PhD degree from the London School of Economics.
Jeffrey Luber, president and CEO of Exact Sciences, said: “We are fortunate to have Mr Singer join the board at this stage of our strategic process. In addition to being a long-time shareholder of the company, he brings M&A, licensing, and partnership deal experience that can be a significant asset in our pursuit of a strategic transaction.”